Aptose Biosciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch APTO and buy or sell other stocks, ETFs, and their options commission-free!

About APTO

Aptose Biosciences, Inc. is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. Its product pipeline includes APTO-253, a small molecule that induces expression of the Kruppel-Like Factor 4 genes; and CG-806 a non-covalent small molecule therapeutic agent. 

CEO
William G. Rice
CEOWilliam G. Rice
Employees
35
Employees35
Headquarters
Toronto, Ontario
HeadquartersToronto, Ontario
Founded
1986
Founded1986
Employees
35
Employees35

APTO Key Statistics

Market cap
204.83M
Market cap204.83M
Price-Earnings ratio
-0.90
Price-Earnings ratio-0.90
Dividend yield
—
Dividend yield—
Average volume
505.12K
Average volume505.12K
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$0.9999
52 Week high$0.9999
52 Week low
$0.36
52 Week low$0.36
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.